
New Target SNX-B8 Aims to Treat Neurodegenerative Disorders

Scientists of the LMU of Munich identified a novel member of a subgroup of the sorting nexin family, SNX-B8 also denoted as SNX-30. In the present invention this novel attributed sorting nexin activity modifies the alpha and beta secretase cleavage of amyloid precursor protein (APP) by controlling its endocytic trafficking.
Further Information: PDF
Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V.
Phone: +49 (0)89/1205-6000
Contact
Dr. Wolfgang Knappe